Pinheiro, Lucas Barboza Moreira; Tao, Songsheng; Culbertson, Elizabeth; Araujo, Gabriel Lima Barros de 
; Billinge, Simon J. L; Ferreira, Fabio Furlan
Source: International Journal of Pharmaceutics. Unidade: FCF
Subjects: CORONAVIRUS, ANTIVIRAIS, DIFRAÇÃO POR RAIOS X, ANTIRRETROVIRAIS, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINHEIRO, Lucas Barboza Moreira et al. Evaluation of the polymorphic forms of ritonavir and lopinavir in raw materials and co-milled systems. International Journal of Pharmaceutics, v. 628, p. 1-9 art. 122329, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2022.122329. Acesso em: 06 nov. 2024.APA
Pinheiro, L. B. M., Tao, S., Culbertson, E., Araujo, G. L. B. de, Billinge, S. J. L., & Ferreira, F. F. (2022). Evaluation of the polymorphic forms of ritonavir and lopinavir in raw materials and co-milled systems. International Journal of Pharmaceutics, 628, 1-9 art. 122329. doi:10.1016/j.ijpharm.2022.122329NLM
Pinheiro LBM, Tao S, Culbertson E, Araujo GLB de, Billinge SJL, Ferreira FF. Evaluation of the polymorphic forms of ritonavir and lopinavir in raw materials and co-milled systems [Internet]. International Journal of Pharmaceutics. 2022 ; 628 1-9 art. 122329.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122329Vancouver
Pinheiro LBM, Tao S, Culbertson E, Araujo GLB de, Billinge SJL, Ferreira FF. Evaluation of the polymorphic forms of ritonavir and lopinavir in raw materials and co-milled systems [Internet]. International Journal of Pharmaceutics. 2022 ; 628 1-9 art. 122329.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.ijpharm.2022.122329
